• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10607
Medical Device Problem Code Material Deformation (2976)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 08/24/2020
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that stent damage occurred.While outside the patient, an attempt to advance a 3.00 x 38 synergy ii drug eluting stent through a watchdog hemostasis valve was made, but the stent became snagged inside the watchdog.The stent was removed and was noted to be damaged.The procedure was completed with another of the same device.No patient complications were reported in relation to this event.
 
Additional Manufacturer Narrative
Device evaluated by mfr: a 3.00 x 38mm synergy ii stent delivery system (sds) was returned for analysis.A visual examination of the stent found signs of stent damage.The distal end of the stent was lifted and pulled distally.The undamaged stent od (outer diameter) was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed signs of distal tip damage.A visual and tactile examination of the hypotube found no issues.A visual examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.No other issues were identified during the product analysis.
 
Event or Problem Description
It was reported that stent damage occurred.While outside the patient, an attempt to advance a 3.00 x 38 synergy ii drug eluting stent through a watchdog hemostasis valve was made, but the stent became snagged inside the watchdog.The stent was removed and was noted to be damaged.The procedure was completed with another of the same device.No patient complications were reported in relation to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10541214
Report Number2134265-2020-12799
Device Sequence Number13529038
Product Code NIQ
UDI-Device Identifier08714729840411
UDI-Public08714729840411
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/18/2021
Device Model Number10607
Device Catalogue Number10607
Device Lot Number0024977493
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2020
Initial Date Received by Manufacturer 08/24/2020
Supplement Date Received by Manufacturer11/03/2020
Initial Report FDA Received Date09/16/2020
Supplement Report FDA Received Date11/19/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-